What to expect when you take Tolbutamide and have Impairment of speech?

Do you take Tolbutamide and have Impairment of speech? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our independent and original studies have been referenced on 400+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Aug, 20, 2018

85 reports have been studied.


Females aged 50 to 59 :

40 related reports were analyzed:

Most common symptoms:

Ascites (accumulation of fluid in the abdominal cavity)
  • 15.0% for females aged 50 (±5) who take Tolbutamide
Dizziness
  • 15.0% for females aged 50 (±5) who take Tolbutamide
Fatigue (feeling of tiredness)
  • 22.5% for females aged 50 (±5) who take Tolbutamide
Nausea and vomiting
  • 22.5% for females aged 50 (±5) who take Tolbutamide

Most common co-existing conditions:

  • n/a
back to top

Males aged 50 to 59 :

45 related reports were analyzed:

Most common symptoms:

Metastases to liver (cancer spreads to liver)
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Mucosal inflammation (infection of mucous membrane)
  • 11.11% for males aged 50 (±5) who take Tolbutamide
Neoplasm malignant (cancer tumour)
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Pneumonia
  • 15.56% for males aged 50 (±5) who take Tolbutamide

Most common co-existing conditions:

Anaemia (lack of blood)
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Analgesic therapy
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Antiallergic therapy
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Blood antidiuretic hormone decreased
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Blood corticotrophin decreased
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Blood follicle stimulating hormone decreased
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Blood glucose increased
  • 11.11% for males aged 50 (±5) who take Tolbutamide
Blood luteinising hormone decreased
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Blood thyroid stimulating hormone decreased
  • 13.33% for males aged 50 (±5) who take Tolbutamide
High blood cholesterol
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults)
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Renal cell carcinoma (a kidney cancer)
  • 15.56% for males aged 50 (±5) who take Tolbutamide
back to top

Related studies

tolbutamide

Tolbutamide has active ingredients of tolbutamide. It is often used in diabetes. (latest outcomes from Tolbutamide 588 users)

impairment of speech

Impairment of speech has been reported by people with multiple sclerosis, high blood pressure, depression, pain, rheumatoid arthritis (latest reports from 47,726 Impairment of speech patients).

Tolbutamide and Impairment of speech

Analysis tools (to study 499 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Tolbutamide, Impairment of speech

Recent updates

General studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.